Shares of agricultural technology company Cibus ( CBUS ) fell over 20% premarket on Thursday after pricing a public offering of 6,976,744 shares at $2.15 per share. The company has also granted the underwriter a 30-day option to purchase up to an additional 1,046,511 shares of Class A Common Stock to cover over-allotments, if any. The gross proceeds will be around $15M (or $17.2M if the underwrite...
Shares of agricultural technology company Cibus ( CBUS ) fell over 20% premarket on Thursday after pricing a public offering of 6,976,744 shares at $2.15 per share. The company has also granted the underwriter a 30-day option to purchase up to an additional 1,046,511 shares of Class A Common Stock to cover over-allotments, if any. The gross proceeds will be around $15M (or $17.2M if the underwriter exercises its option to purchase additional shares of Class A Common Stock in full). The offering is expected to close on March 27, 2026. The company currently intends to use the net proceeds from the offering for working capital and general corporate purposes, including to fund further development of its weed management traits in rice. Source: Press Release More on Cellectis, Cibus Cellectis S.A. (CLLS) Q4 2025 Earnings Call Transcript Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript Cibus' Agri-Bio Gamble - Technology Is Promising, Cash Is Limited, Execution Is Key Cibus announces public offering of Class A common stock and pre-funded warrants Cibus targets $200M annual rice royalties with expanded Latin America and India push while advancing biofragrance commercialization
The S&P 500 has had its ups and downs over the past three years, but its general trend was in one direction: upward. The famous benchmark soared as investors favored growth stocks, particularly those operating in the area of artificial intelligence (AI). This field is seen as incredibly promising, as it may help companies become more profitable -- AI can do this by helping them streamline operatio...
The S&P 500 has had its ups and downs over the past three years, but its general trend was in one direction: upward. The famous benchmark soared as investors favored growth stocks, particularly those operating in the area of artificial intelligence (AI). This field is seen as incredibly promising, as it may help companies become more profitable -- AI can do this by helping them streamline operations or more easily innovate, to name two examples. In recent times, though, the S&P 500 and many of the stocks that have led the increase have lost much of this positive momentum. They haven't taken a clear direction, and instead have fluctuated between gains and losses. Investors have worried about the impact of geopolitical troubles and the economy on the market, and uncertainty about the AI revenue opportunity has also circulated. Against this backdrop, investors are keen to know what may be next for the S&P 500. The stock market might offer us a clue: It's flashed a warning sign for the first time since the dot-com bubble, and history offers us a remarkably clear idea of what could lie ahead. Continue reading
Nouveau Monde Graphite press release ( NMG ): Q4 GAAP EPS of C$0.03. More on Nouveau Monde Graphite Inc. Nouveau Monde Graphite secures $335M financing commitment for Matawinie Mine Historical earnings data for Nouveau Monde Graphite Inc. Financial information for Nouveau Monde Graphite Inc.
Nouveau Monde Graphite press release ( NMG ): Q4 GAAP EPS of C$0.03. More on Nouveau Monde Graphite Inc. Nouveau Monde Graphite secures $335M financing commitment for Matawinie Mine Historical earnings data for Nouveau Monde Graphite Inc. Financial information for Nouveau Monde Graphite Inc.
(RTTNews) - While reporting financial results for the second quarter on Thursday, Commercial Metals Co. (CMC) said it is well-positioned to drive further growth during the second half of fiscal 2026.
(RTTNews) - While reporting financial results for the second quarter on Thursday, Commercial Metals Co. (CMC) said it is well-positioned to drive further growth during the second half of fiscal 2026.
Ascentage Pharma Group International press release ( AAPG ): FY GAAP EPS of $0.50 beats by $1.66 . Revenue of $82.1M (-38.9% Y/Y) beats by $1.96M . Gross profit declined to $75.1K in 2025 from ¥ 951,565 (~$132.16M) in 2024. More on Ascentage Pharma Group International Ascentage Pharma Group International (AAPG) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Asce...
Ascentage Pharma Group International press release ( AAPG ): FY GAAP EPS of $0.50 beats by $1.66 . Revenue of $82.1M (-38.9% Y/Y) beats by $1.96M . Gross profit declined to $75.1K in 2025 from ¥ 951,565 (~$132.16M) in 2024. More on Ascentage Pharma Group International Ascentage Pharma Group International (AAPG) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on Ascentage Pharma Group International Historical earnings data for Ascentage Pharma Group International
A Los Angeles jury has found Google liable for the design of YouTube contributing to youth social media addiction and related mental health issues. The verdict is the first in thousands of similar lawsuits challenging long standing legal protections for tech platforms. The decision raises new legal, regulatory, and business risks for Alphabet and could influence how core products are designed and ...
A Los Angeles jury has found Google liable for the design of YouTube contributing to youth social media addiction and related mental health issues. The verdict is the first in thousands of similar lawsuits challenging long standing legal protections for tech platforms. The decision raises new legal, regulatory, and business risks for Alphabet and could influence how core products are designed and overseen. Alphabet, trading under NasdaqGS:GOOGL, comes into this verdict with a mixed recent...